Medicare Enrolled
Dr. Anju Vasudevan, M. D.
Hematology & Oncology · Ocala, FL
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Mixed engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Vasudevan from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Vasudevan? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Vasudevan
Dr. Anju Vasudevan is a hematology & oncology in Ocala, FL, with 20 years in practice. Based on federal Medicare data, Dr. Vasudevan performed 213,076 Medicare services across 8,336 unique beneficiaries.
Between the years covered by Open Payments, Dr. Vasudevan received a total of $54,324 from 109 pharmaceutical and/or device companies across 1427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Vasudevan is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in FL$ $54,324 industry payments
Medicare Practice Summary
Medicare Utilization ↗213,076
Medicare services
Top 2% in FL for hematology & oncology
8,336
Unique beneficiaries
$12
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~10,654 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Filgrastim injection (Zarxio) for white blood cells | 50,040 | $0 | $2 |
| Darbepoetin injection (Aranesp) for anemia | 34,480 | $2 | $21 |
| Pembrolizumab injection (Keytruda) | 28,600 | $43 | $146 |
| Azacitidine chemotherapy injection | 22,800 | $0 | $14 |
| Iron infusion (Monoferric) | 11,800 | $17 | $75 |
| Denosumab injection (Prolia/Xgeva) | 10,800 | $18 | $70 |
| Contrast dye for imaging (iodine-based) | 7,325 | $0 | $3 |
| Iron infusion (Feraheme) | 7,140 | $0 | $6 |
| Anti-nausea injection (fosaprepitant) | 6,750 | $0 | $6 |
| Immune globulin infusion (Octagam) | 3,894 | $34 | $252 |
| Complete blood count (CBC) with differential | 3,756 | $8 | $35 |
| Blood draw (venipuncture) | 3,588 | $8 | $19 |
| Comprehensive metabolic blood panel | 2,379 | $10 | $62 |
| Epoetin alfa injection (Retacrit) for anemia | 2,310 | $6 | $30 |
| Dexamethasone injection (steroid) | 1,332 | $0 | $1 |
| Iron binding capacity test | 1,180 | $9 | $34 |
| Iron level test | 1,179 | $6 | $26 |
| Ferritin level test (iron stores) | 1,177 | $13 | $58 |
| Anti-nausea injection (Aloxi/palonosetron) | 960 | $1 | $122 |
| Office visit, established patient (30-39 min) | 840 | $90 | $224 |
| Injection, granisetron hydrochloride, 100 mcg | 790 | $0 | $25 |
| Drug injection, under skin or into muscle | 672 | $10 | $93 |
| Lactate dehydrogenase (enzyme) level | 645 | $6 | $30 |
| Office visit, established patient (20-29 min) | 589 | $66 | $148 |
| Injection, magnesium sulfate, per 500 mg | 496 | $1 | $6 |
| Injection of additional new drug or substance into vein | 441 | $12 | $105 |
| Administration of chemotherapy into vein, 1 hour or less | 440 | $100 | $686 |
| Folic acid level test | 405 | $14 | $71 |
| Vitamin B-12 level test | 404 | $15 | $74 |
| Measurement of substance using immunoassay technique | 392 | $17 | $181 |
| Nephelometry, test method using light | 392 | $13 | $176 |
| Injection, pegfilgrastim-apgf (nyvepria), biosimilar, 0.5 mg | 318 | $93 | $879 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 310 | $49 | $304 |
| Injection, carboplatin, 50 mg | 249 | $2 | $300 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 231 | $20 | $124 |
| Infusion, normal saline solution, sterile (500 ml = 1 unit) | 217 | $1 | $19 |
| Antibody identification test, platelet associated immunoglobulin assay | 210 | $12 | $155 |
| Thyroid stimulating hormone (TSH) test | 191 | $16 | $78 |
| Magnesium level test | 190 | $7 | $28 |
| Basic metabolic blood panel | 182 | $8 | $48 |
| Measurement of immunoglobulin light chains | 176 | $17 | $60 |
| Carcinoembryonic antigen (cea) protein level | 166 | $19 | $96 |
| Infusion into a vein for hydration, 31-60 minutes | 161 | $24 | $248 |
| Infusion into a vein for therapy, prevention, or diagnosis, each additional hour | 140 | $16 | $97 |
| Stool analysis for blood, by fecal hemoglobin determination by immunoassay | 136 | $16 | $70 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 134 | $55 | $205 |
| Hospital follow-up visit, moderate complexity | 130 | $64 | $157 |
| Adrenocorticotropic hormone (acth) level | 126 | $38 | $166 |
| Initial hospital care with straightforward or low level of medical decision making, per day, if using time, at least 40 minutes | 108 | $67 | $214 |
| Injection, diphenhydramine hcl, up to 50 mg | 106 | $1 | $7 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 103 | $1 | $19 |
| Administration of additional new drug or substance into vein, 1 hour or less | 100 | $50 | $334 |
| Irrigation of implanted venous access drug delivery device | 91 | $18 | $111 |
| Collection of blood sample from implanted device | 89 | $19 | $64 |
| Administration of chemotherapy into vein, each additional hour | 86 | $22 | $156 |
| Infusion into a vein for hydration, each additional hour | 85 | $10 | $73 |
| Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less | 85 | $22 | $152 |
| Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 84 | $410 | $638 |
| Nuclear medicine study from skull base to mid-thigh with ct scan | 83 | $1,210 | $4,120 |
| Hospital follow-up visit, high complexity | 73 | $96 | $232 |
| Infusion, normal saline solution , 1000 cc | 67 | $2 | $19 |
| Ct scan of chest with contrast | 66 | $82 | $1,005 |
| CT scan of abdomen and pelvis with contrast | 65 | $216 | $1,400 |
| Uric acid level test | 60 | $4 | $24 |
| New patient office visit (45-59 min) | 59 | $126 | $343 |
| Office visit, established patient, complex (40-54 min) | 57 | $129 | $301 |
| Administration of additional new drug or substance into vein using push technique | 47 | $43 | $281 |
| Drawing of blood for a medical problem | 37 | $67 | $251 |
| Unclassified drugs | 31 | $1 | $9 |
| Injection of drug or substance into vein | 30 | $29 | $240 |
| Ct scan of abdomen and pelvis without contrast | 28 | $130 | $892 |
| CT scan of chest, without contrast | 26 | $69 | $861 |
| PSA test (prostate cancer screening) | 26 | $18 | $91 |
| Injection, alteplase recombinant, 1 mg | 26 | $64 | $225 |
| Beta-2 microglobulin (protein) level | 25 | $16 | $93 |
| Biopsy and aspiration of bone marrow sample for diagnosis | 22 | $138 | $523 |
| Automated urinalysis | 20 | $2 | $16 |
| Infusion, normal saline solution, 250 cc | 15 | $1 | $19 |
| Declotting of central venous tube | 13 | $24 | $117 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
11.2% high complexity
79.6% medium
9.2% routine
Industry Payment Transparency
Open Payments through 2024 ↗$54,324
Total received (2018-2024)
Avg $7,761/year across 7 years
Top 14% in FL for hematology & oncology
109
Companies
1,427
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$26,054 (48.0%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$19,321 (35.6%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$7,803 (14.4%)
Other
Charitable contributions, space rental, and other categories
$1,146 (2.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$5,563
2023$6,682
2022$11,709
2021$8,642
2020$11,731
2019$7,335
2018$2,662
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AstraZeneca Pharmaceuticals LP
$4,418
BeiGene USA, Inc.
$4,338
Seattle Genetics, Inc.
$3,891
Novartis Pharmaceuticals Corporation
$3,563
Incyte Corporation
$3,518
Janssen Biotech, Inc.
$2,839
E.R. Squibb & Sons, L.L.C.
$2,410
Jazz Pharmaceuticals Inc.
$2,193
SERVIER PHARMACEUTICALS LLC
$1,876
G1 Therapeutics, Inc.
$1,690
Celgene Corporation
$1,447
Blueprint Medicines Corporation
$1,286
Amgen Inc.
$1,264
PFIZER INC.
$1,143
Astellas Pharma US Inc
$936
Janssen Scientific Affairs, LLC
$873
Daiichi Sankyo Inc.
$843
Seagen Inc.
$843
Lilly USA, LLC
$817
Merck Sharp & Dohme Corporation
$728
Merck Sharp & Dohme LLC
$657
GENZYME CORPORATION
$574
Genentech USA, Inc.
$556
Takeda Pharmaceuticals U.S.A., Inc.
$489
Eisai Inc.
$483
Alexion Pharmaceuticals, Inc.
$461
GlaxoSmithKline, LLC.
$461
Regeneron Healthcare Solutions, Inc.
$454
BeiGene, Ltd.
$450
JAZZ PHARMACEUTICALS INC.
$431
Pharmacosmos Therapeutics Inc.
$418
Bayer HealthCare Pharmaceuticals Inc.
$392
Gilead Sciences, Inc.
$370
Pharmacyclics LLC, An AbbVie Company
$359
Ipsen Biopharmaceuticals, Inc
$347
Kite Pharma, Inc.
$281
Puma Biotechnology, Inc.
$275
Genmab U.S., Inc.
$255
Boehringer Ingelheim Pharmaceuticals, Inc.
$254
EISAI INC.
$240
TESARO, Inc.
$230
AVEO Pharmaceuticals, Inc.
$202
Dova Pharmaceuticals
$201
Mirati Therapeutics, Inc.
$187
Foundation Medicine, Inc.
$181
Karyopharm Therapeutics Inc.
$168
Pharmacyclics LLC, an AbbVie Company
$168
Rigel Pharmaceuticals, Inc.
$165
Agios Pharmaceuticals, Inc.
$164
Bayer Healthcare Pharmaceuticals Inc.
$163
EMD Serono, Inc.
$157
Exelixis Inc.
$152
Heron Therapeutics, Inc.
$138
PharmaEssentia USA Corporation
$135
Lexicon Pharmaceuticals, Inc.
$134
ARRAY BIOPHARMA INC
$127
SOBI, INC
$126
Stemline Therapeutics Inc.
$123
Myriad Genetic Laboratories, Inc.
$119
Kyowa Kirin, Inc.
$118
CSL Behring
$118
MorphoSys, US Inc.
$116
ABBVIE INC.
$113
Novocure Inc.
$113
Epizyme, Inc.,
$94
Global Blood Therapeutics, Inc.
$91
TG THERAPEUTICS, INC.
$89
PUMA BIOTECHNOLOGY, INC.
$86
AbbVie Inc.
$83
TerSera Therapeutics LLC
$61
Apellis Pharmaceuticals, Inc.
$61
Servier Pharmaceuticals LLC
$53
Octapharma USA, Inc.
$53
SUN PHARMACEUTICAL INDUSTRIES INC.
$47
TG Therapeutics, Inc.
$46
EUSA Pharma (US) LLC
$45
Helsinn Therapeutics (U.S.), Inc.
$40
Sun Pharmaceutical Industries Inc.
$39
Sobi, Inc
$38
Deciphera Pharmaceuticals Inc.
$38
Immunocore Limited
$36
Adaptive Biotechnologies Corporation
$33
Horizon Therapeutics plc
$32
CTI BioPharma Corp.
$32
TAIHO ONCOLOGY, INC.
$31
Clovis Oncology, Inc.
$30
Teva Pharmaceuticals USA, Inc.
$30
Emmaus Medical, Inc.
$29
MEDIVATION FIELD SOLUTIONS LLC
$26
Secura Bio, Inc.
$25
Janssen Pharmaceuticals, Inc
$22
Amneal Pharmaceuticals LLC
$20
Medtronic, Inc.
$20
Array BioPharma Inc.
$19
ADC Therapeutics America, Inc.
$19
Taiho Oncology, Inc.
$19
Verastem, Inc.
$19
Geron Corporation
$19
GE HealthCare
$18
Shire North American Group Inc
$15
Verity Pharmaceuticals Inc.
$15
Alnylam Pharmaceuticals Inc.
$15
Aveo Pharmaceuticals, Inc.
$14
Acrotech Biopharma LLC
$14
Coherus Biosciences Inc.
$14
AbbVie, Inc.
$13
INSYS Therapeutics Inc
$12
Dendreon Pharmaceuticals LLC
$12
GE HEALTHCARE
$10
Top 3 companies account for 23.3% of total payments
Associated products mentioned in payments ›
ABECMA · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ALUNBRIG · AUGTYRO · AVASTIN · AYVAKIT · Afstyla · Alecensa · Aliqopa · Aranesp · BALVERSA · BAVENCIO · BELEODAQ · BENDEKA · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Balversa · Bavencio · Blincyto · Braftovi · CABOMETYX · CALQUENCE · CERDELGA · CEREZYME · CINVANTI · COPIKTRA · COSELA · CREON · CYRAMZA · Cabometyx · Cinvanti · Copiktra · Creon · DARZALEX · DOPTELET · Doptelet · ELAHERE · ELITEK · ELREXFIO · EMPRINT · ENHERTU · ENJAYMO · EPKINLY · ERBITUX · ERLEADA · EVENITY · EXKIVITY · Empaveli · Endari · Enhertu · Epkinly · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Farydak · GAUCHER-DISEASE · GAVRETO · GAZYVA · GILOTRIF · GIVLAARI · Gazyva · Halaven · IBRANCE · ICLUSIG · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · INREBIC · Idelvion · Imbruvica · Inrebic · JAKAFI · JEMPERLI · JEVTANA · Jivi · KANJINTI · KEYTRUDA · KIMMTRAK · KISQALI · KRAZATI · KRYSTEXXA · Kyprolis · LIBTAYO · LONSURF · LORBRENA · LUMAKRAS · LUTATHERA · LYNPARZA · Lenvima · Lunsumio · MEKINIST · MEKTOVI · MONJUVI · MONOFERRIC · MVASI · MYLOTARG · MYRISK · Monoferric · NERLYNX · NINLARO · Nerlynx · Neulasta · Nplate · Nubeqa · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ODOMZO · OJJAARA · ONIVYDE · ONUREG · OPDIVO · OPDUALAG · OXBRYTA · Oncology · Onivyde · Optune Lua (NovoTTF-200T) · Orserdu · PADCEV · PANZYGA · PEMAZYRE · PIQRAY · PLUVICTO · POTELIGEO · PROMACTA · PROSTATE CANCER - DISEASE · PROVENGE · PYRUKYND · Padcev · Perjeta · Phesgo · Polivy · Pomalyst · Poteligeo · Prolia · QINLOCK · REBLOZYL · RETEVMO · RYBREVANT · RYDAPT · RYTELO · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SARCLISA · SCEMBLIX · SHINGRIX · SOLIRIS · SOMATULINE DEPOT · SPRYCEL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · Sylvant · TABRECTA · TAGRISSO · TALVEY · TASIGNA · TAZVERIK · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tibsovo · Trelstar · Trodelvy · UKONIQ · ULTOMIRIS · Udenyca · Ultomiris · VENCLEXTA · VERZENIO · VOTRIENT · VYXEOS · Venclexta · Vitrakvi · Vonjo · XALKORI · XGEVA · XOSPATA · XPOVIO · XTANDI · Xermelo · Xofigo · Xospata · Xtandi · YONSA · YONSA (abiraterone acetate) · Yescarta · ZEJULA · ZEPZELCA · ZOLADEX · Zoladex · clonoSEQ · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (48%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $26 per 100 Medicare services performed
Geographic Context
Hematology & Oncologys within 10 mi
6
Per 100K population
1.5
County median income
$58,535
Nearest hospital
ADVENTHEALTH OCALA
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Vasudevan is a mixed practice specialist, with above-average Medicare volume (top 2% in FL), and high industry engagement (mixed engagement, top 14%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Vasudevan experienced with filgrastim injection (zarxio) for white blood cells?
Based on Medicare claims data, Dr. Vasudevan performed 50,040 filgrastim injection (zarxio) for white blood cells services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Vasudevan receive payments from pharmaceutical companies?
Yes. Dr. Vasudevan received a total of $54,324 from 109 companies across 1,427 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Vasudevan's costs compare to other hematology & oncologys in Ocala?
Dr. Vasudevan's average Medicare payment per service is $12. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Vasudevan) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncologys in Ocala
Browse hematology & oncologys in Ocala ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncologys in FL
Hematology & Oncologys ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncologys in FL
Which FL hematology & oncologys receive the most from drug and device companies.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
By company
BeiGene USA, Inc. Payments to Doctors
See all physicians who received payments from BeiGene USA, Inc..
By company
Seattle Genetics, Inc. Payments to Doctors
See all physicians who received payments from Seattle Genetics, Inc..
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology